TY  - GEN
AU  - Beglinger,Ch
TI  - [Treatment of Crohn's disease]
SN  - 0040-5930
PY  - 2003///0519
KW  - Acute Disease
KW  - Adjuvants, Immunologic
KW  - therapeutic use
KW  - Adrenal Cortex Hormones
KW  - administration & dosage
KW  - Algorithms
KW  - Aminosalicylic Acids
KW  - Anti-Bacterial Agents
KW  - Anti-Inflammatory Agents
KW  - Anti-Inflammatory Agents, Non-Steroidal
KW  - Antibodies, Monoclonal
KW  - Azathioprine
KW  - Budesonide
KW  - Case-Control Studies
KW  - Clinical Trials as Topic
KW  - Crohn Disease
KW  - drug therapy
KW  - Drug Therapy, Combination
KW  - Gastrointestinal Agents
KW  - Humans
KW  - Immunosuppressive Agents
KW  - Infliximab
KW  - Mesalamine
KW  - Methotrexate
KW  - Metronidazole
KW  - Osteoporosis
KW  - chemically induced
KW  - Prednisolone
KW  - Prednisone
KW  - Randomized Controlled Trials as Topic
KW  - Time Factors
N1  - Publication Type: Comparative Study; English Abstract; Journal Article; Review
UR  - https://doi.org/10.1024/0040-5930.60.3.159
ER  -